So far I know, Scopus (Elsevier) have already started such matric for their indexed journals - which is far more vast than the Thomson Reuters impact factor list.

Thanks.

In response to:

Shibabrata Pattanayak

SCOPUS is widely used however, as a publisher, Elsevier is clearly having a very high risk conflict of interest that can not be denied whatever they claim. They will only provide IF for their own indexed journals. For the Same journal I have seen two reports from SCOPUS and PubMed. The indexation assessors method and their responses are much subjective than indexation by the PubMed. The Embargo period is 5 years whereas PubMed is only 2 years. Their reports are simply a free text message that comes a an email whereas the reports from PubMed provides the editors with itemized response based on the criteria of the selection in a table format and scores. "The editorial Board looks as if it mainly a group of diaspora physicians from XXXXX region". How that helps a decision to select or not select. I strongly encourage emerging medical Journals (non-predatory of course) to focus on meeting the criteria for and timely apply for PuBMd entry (PMC or Medline). All other indexation databases made by others who may have a potential conflict of interest should be kept under scrutiny

Hi,

The Publish or Perish (PoP) database that is free for downloading, provides many indicators , based on GS data. If you search the data on a certain journal, this database produces many useful impact and influence results.

Yes, nice reply by Avishag Gordon.